Tau Therapeutics for Alzheimer’s Disease : The Promise and the Challenges

By Gold Michael  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 329-334

Humana Press, Inc

Access to resources Recommend Favorite

Signal Transduction Therapeutics: Relevance for Alzheimer's Disease

By da Cruz e Silva Odete A. B.   Fardilha Margarida   Henriques Ana Gabriela   Rebelo Sandra   Vieira Sandra   da Cruz e Silva Edgar F.  

Journal of Molecular Neuroscience, Vol. 23, Iss. 1-2, 2004-04 ,pp. : 123-142

Humana Press, Inc

Access to resources Recommend Favorite

Nucleic Acid Aptamers as Novel Class of Therapeutics to Mitigate Alzheimer's Disease Pathology

By  

Current Alzheimer Research, Vol. 10, Iss. 4, 2013-05 ,pp. : 442-448

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer’s therapeutics: Neurotrophin domain small molecule mimetics

By Massa Stephen   Xie Youmei   Longo Frank  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 323-326

Humana Press, Inc

Access to resources Recommend Favorite

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 151-155

Humana Press, Inc

Access to resources Recommend Favorite